Norwood Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Norwood Financial's BIIB Position: Q1 2024 in Review
Norwood Financial held its Biogen (BIIB) position steady in Q1 2024 at 355 shares worth $76.5K. The position accounts for 0.11% of the portfolio, ranked #136.
Norwood Financial first reported a position in BIIB in Q4 2021 and has held it in 10 quarters since. The position peaked at $113K in Q1 2023. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.
- Norwood Financial held 355 shares of Biogen worth $76.5K as of Q1 2024.
- Norwood Financial left its Biogen share count unchanged in Q1 2024.
- Biogen made up 0.11% of Norwood Financial's portfolio in Q1 2024, its #136 holding.
- Norwood Financial first reported a position in Biogen in Q4 2021 and has held it in 10 quarters since.
- Norwood Financial's Biogen position peaked at $113K in Q1 2023.
- 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.
Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.